Extract from the Register of European Patents

EP About this file: EP0548664

EP0548664 - 2,3,3a-5,9b-hexahydro-1H-benzo(e)indole derivatives [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.04.1996
Database last updated on 26.03.2026
Most recent event   Tooltip04.04.1996No opposition filed within time limitpublished on 22.05.1996 [1996/21]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Postfach 3255
4002 Basel / CH
[N/P]
Former [1993/26]For all designated states
F. HOFFMANN-LA ROCHE AG
Postfach 3255
CH-4002 Basel / CH
Inventor(s)01 / Bruderer, Hans
4 Schulgasse
CH-4105 Biel-Benken / CH
02 / Godel, Thierry
1 Lenweg
CH-4153 Reinach / CH
03 / Imhof, René
3 Bleumatthöhe
CH-5264 Gipf-Oberfrick / CH
04 / Jakob-Roetne, Roland
26 Oberer Baselblick
W-7854 Inzlingen / DE
[1993/26]
Representative(s)Bertschinger, Christoph, et al
F.Hoffmann-La Roche AG
Patent Department (PLP),124 Grenzacherstrasse
4070 Basel / CH
[N/P]
Former [1993/26]Bertschinger, Christoph, Dr., et al
Grenzacherstrasse 124 P.O. Box 3255
CH-4002 Basel / CH
Application number, filing date92120925.009.12.1992
[1993/26]
Priority number, dateCH1991000380620.12.1991         Original published format: CH 380691
CH1992000325419.10.1992         Original published format: CH 325492
[1993/26]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP0548664
Date:30.06.1993
Language:DE
[1993/26]
Type: B1 Patent specification 
No.:EP0548664
Date:31.05.1995
Language:DE
[1995/22]
Search report(s)(Supplementary) European search report - dispatched on:EP20.04.1993
ClassificationIPC:C07D209/60, A61K31/40
[1993/26]
CPC:
C07D209/60 (EP,US); A61P25/28 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1993/26]
TitleGerman:2,3,3a,4,5,9b-Hexahydro-1H-benzo[e]indol-Derivate[1993/26]
English:2,3,3a-5,9b-hexahydro-1H-benzo(e)indole derivatives[1993/26]
French:Dérivés de 2,3,3a,5,9b-hexahydro-1H-benzo(e)indole[1993/26]
Examination procedure09.12.1992Examination requested  [1993/26]
08.03.1994Despatch of a communication from the examining division (Time limit: M06)
08.09.1994Reply to a communication from the examining division
14.10.1994Despatch of communication of intention to grant (Approval: Yes)
07.12.1994Communication of intention to grant the patent
07.02.1995Fee for grant paid
07.02.1995Fee for publishing/printing paid
Opposition(s)01.03.1996No opposition filed within time limit [1996/21]
Fees paidRenewal fee
16.12.1994Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]   CHIM. THER. Bd. 7, Nr. 6, 1972, Seiten 450 - 458 M. LANGLOIS ET AL. 'Recherches dans la srie des aryl-3 pyrrolidines III. Prparation de drivs du benzo(e)indole et de l'indano(1,2b)pyrrole' [Y]
 [Y]   J. PHARM. PHARMACOL. Bd. 43, 1991, Seiten 11 - 16 I. DEN DAAS ET AL. 'Orally Active Carbamate Prodrugs of the Selective Dopamine Agonist N-0437: In-vivo Activities in the 6-OHDA Turning Model and In-vitro Activities' [Y]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.